Skip to content

Experimental study on elderly health management based on personalized intervention

Experimental study on elderly health management based on personalized intervention

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500101978
Enrollment
Unknown
Registered
2025-05-06
Start date
2025-05-10
Completion date
Unknown
Last updated
2025-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy individuals or elderly patients with chronic diseases

Interventions

control group:Conventional Health Management
intervention group:Personalized intervention plan

Sponsors

Shanghai University of Medicine and Health Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1 Age >= 60 years old; 2 Meet the health examination requirements; 3 Capable of completing questionnaire surveys and lifestyle assessments.

Exclusion criteria

Exclusion criteria: 1 Individuals with hearing, visual, cognitive impairments, or self-reported neurological and psychiatric disorders such as epilepsy or dementia who are unable to communicate, interact, and learn normally; 2 Individuals with unstable vital signs; 3 Individuals who self report having diseases such as cardiovascular, cerebrovascular, renal, liver, respiratory, and hematological disorders, and are intolerant to exercise (as advised by a doctor or assessed on-site by an evaluator); 4 Individuals with severe anxiety (Hamilton Anxiety Scale HAMA total score >= 29 points); 5 Severe depression patients (HAMD-24 total score >= 35 points); Merge individuals with other mental illnesses; 6 There are serious complications such as heart failure, respiratory failure, liver failure, kidney failure, acute myocardial infarction, and severe pulmonary infection. Unstable vital signs, combined with other important organ diseases, severe deformities, severe infections, and malignant tumors; 7 Individuals with consciousness disorders, cognitive impairments, severe aphasia, loss of recognition, and inability to communicate; 8 Recently participated in other clinical trials; 9 Not willing to sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
Disease control situation;

Secondary

MeasureTime frame
SF-36 Health Survey Questionnaire;GAD-7 Generalized anxiety disorder;PHQ-9 Patient Health Questionnaire-9;

Countries

China

Contacts

Public ContactGuo Jiachen(Gao Yu)

Shanghai University of Medicine and Health Sciences

zpp18549813423@163.com+86 185 4981 3423

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026